NFKB1 and obesity disorder: In conclusion, this study revealed that inhibiting oxidative stress and NF-κB-mediated inflammation has a marked impact on the progression of T2D, and in doing so, also maintains metabolic homeostasis, thereby improving NAFLD and hepatic insulin resistance in obesity.